Home
Search

News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
Browse All
New Report Outlines Best Practices in Bioscience…
Today, the Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released a new report on bioscience economic development best practices, “Driving the Bioscience Economy Forward During…
Learn more
CMS’ Attempt to Restrict Patient Access to…
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response to the Centers for Medicare and Medicaid Services’ (CMS) proposed National Coverage Determination (NCD) to…
Learn more
"Build Back Better Act" Drug Pricing Provisions…
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement after the House of Representatives passed the Build Back Better Act: “The legislation that passed the House today…
Learn more
Letters, Testimony, & Comments
Browse All
Senate Finance Committee Leadership Sends Letter…
The United States-Mexico-Canda Agreement has the potential to deliver tangible benefits for America's workers, farmers, and businesses by improving and strengthening the relationship between the United States and its two closest trading partners…
Learn more
BIO Comments on Draft Guidance: Reporting Amount…
On Wednesday, December 29th, BIO submitted comments to the Food and Drug Administration’s recent draft guidance for industry entitled, Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the Federal Food, Drug, and…
Learn more
BIO Comments on Draft Guidance: Q13 Continuous…
On Monday, December 13th, BIO submitted comments to the Food and Drug Administration’s recent draft guidance for industry entitled, Q13 Continuous Manufacturing of Drug Substances and Drug Products. The draft guidance was prepared under the auspices…
Learn more
Amicus Briefs
Browse All
BIO Files Amicus Brief in Petition for a Writ of…
BIO and AUTM have filed an amicus brief in petition for a writ of certiorari the in American Axle & Manufacturing, Inc., v. Neapco Holdings LLC, et al., at the Supreme Court of the United States. BIO and AUTM are concerned that…
Learn more
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
Learn more
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
Learn more
Blog Posts
Browse all Blogs
Patient and Doctor
To advance health equity, we need ‘just science’
January 13, 2022
With COVID-19 shining an especially bright spotlight on healthcare inequity in the US and internationally, there has been a stronger call to action to ensure that patients across all demographics are receiving the care…
Dont Look Up Climate Change
“Don’t Look Up” Misses Climate Change Solutions in Action
January 12, 2022
Please note this blog contains spoilers for the movie “Don’t Look Up.” The star-studded movie “Don’t Look Up” is an overt allegory for climate change and what can happen when the entire world observes an impending…
BTN-MTC_Patient-Pharmacy.png
Brand Name Drug Prices Fell in 2021 -- Again.
January 7, 2022
It’s a new calendar year – yet the tired drug pricing control policies of 2021 continue to float around Capitol Hill. Proponents of price controls justify their actions by claiming drug prices are “skyrocketing” and…